PURbridge™, an advanced synthetic and new form of bioactive glass, is positioned to significantly increase the Company's revenue throughout 2023 IRVINE, CA / ACCESSWIRE / November 23, 2022 / HippoFi, Inc. (formerly...
RVINE, Calif.--(BUSINESS WIRE)--Today Viseon Inc. announced preliminary results from the clinical use of the MaxView® intraoperative imaging technology compared to traditional imaging modalities during minimally invasive lateral lumbar interbody fusion surgery...
The approval of the STAR PSI System marks an impactful milestone by allowing surgeons to provide a personalized pre-operative plan for their total ankle replacement patients. Wilmington, DE, Dec. 01, 2022...
FOXBOROUGH, Mass., Dec. 1, 2022 /PRNewswire/ -- Shanghai MicroPort MedBot (Group) Co., Ltd. ("MicroPort MedBot") announced that on November 22nd, 2022 MicroPort NaviBot International, LLC in recent collaboration with MicroPort Orthopedics has completed the first clinical use of the...
Study conducted by the Texas Back Institute (TBI), Plano, TX and published in the International Journal of Spine SurgeryThe retrospective study supports utilizing STALIF M portfolio implants as a stand-alone deviceThe STALIF technology platform has a...
Lazurite’s ArthroFree™ System is the first wireless surgical camera system to receive FDA market clearance for arthroscopy and general endoscopy. (Photo: Business Wire) CLEVELAND--(BUSINESS WIRE)--Medical device and technology company Lazurite and...
D-PLEX₁₀₀ Infection Prevention Efficacy in Patients with Increased Risk for Surgical Wound Infections Including Multi-Drug Resistant Organisms (MDROs) will be Presented During a Podium Presentation. PETACH TIKVA, Israel, Nov. 29, 2022 (GLOBE...
IRVINE, Calif.--(BUSINESS WIRE)--Irvine-based Biogennix, a market leader in advanced bone regeneration technology, announced today that its DirectCell Advanced Bone Grafting System has been used in more than 1000 cases as of this quarter. The...
First Actera™ procedure underscores company’s ongoing commitment to advancing joint replacement technology by leveraging its data-driven approach and surgical planning expertise. BILLERICA, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS),...
First investigational trial of drug-biologic bone graft for spinal fusionNo drug-related Serious Adverse Events (SAEs) reported in randomised stage of the trialEnrolment of additional 20 patients for second non-randomised stage...